https://arolstar52-zhtest.hf.space/index.php?action=history&feed=atom&title=ADBICA
ADBICA - 版本历史
2026-07-06T00:10:10Z
在这个wiki上该页的修订历史
MediaWiki 1.43.8
https://arolstar52-zhtest.hf.space/index.php?title=ADBICA&diff=4680284&oldid=prev
imported>Jimmy-bot：机器人: 尚未清空的已重定向分类） （Cat:狡詐家藥物→Cat:策划药
2025-08-15T10:26:40Z
<p>机器人: 尚未清空的已重定向分类） （<a href="/index.php?title=Cat:%E7%8B%A1%E8%A9%90%E5%AE%B6%E8%97%A5%E7%89%A9&action=edit&redlink=1" class="new" title="Cat:狡詐家藥物（页面不存在）">Cat:狡詐家藥物</a>→<a href="/index.php?title=Cat:%E7%AD%96%E5%88%92%E8%8D%AF&action=edit&redlink=1" class="new" title="Cat:策划药（页面不存在）">Cat:策划药</a></p>
<p><b>新页面</b></p><div>{{Drugbox<br />
| IUPAC_name = ''N''-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1''H''-indole-3-carboxamide<br />
| image = ADBICA_structure.png<br />
| image_class = skin-invert-image<br />
<br />
<!--Clinical data--><br />
| tradename = <br />
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --><br />
| pregnancy_US = <!-- A / B / C / D / X --><br />
| pregnancy_category = <br />
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --><br />
| legal_CA = Schedule II<br />
| legal_DE = NpSG<br />
| legal_UK = Class B<br />
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --><br />
| legal_status = <br />
| routes_of_administration =<br />
<br />
<!--Pharmacokinetic data--><br />
| bioavailability = <br />
| protein_bound = <br />
| metabolism = <br />
| elimination_half-life = <br />
| excretion =<br />
<br />
<!--Identifiers--><br />
| CAS_number_Ref = {{cascite|correct|??}}<br />
| CAS_number = 1445583-48-1<br />
| ATC_prefix = none<br />
| ATC_suffix = <br />
| PubChem = 72710773<br />
| ChemSpiderID = 29342130<br />
| UNII2_Ref = {{fdacite|correct|FDA}}<br />
| UNII2 = P0248QCZ04<br />
| index2_label = ''S'' isomer<br />
| UNII_Ref = {{fdacite|correct|FDA}}<br />
| UNII = Q71G788A6H<br />
| index_label = racemate<br />
<!--Chemical data--><br />
| C=20 | H=29 | N=3 | O=2<br />
| smiles = CCCCCN1C=C(C2=CC=CC=C21)C(=O)NC(C(=O)N)C(C)(C)C<br />
| smiles2 = CCCCCN1C=C(C2=CC=CC=C21)C(=O)N[C@H](C(=O)N)C(C)(C)C<br />
| StdInChI=1S/C20H29N3O2/c1-5-6-9-12-23-13-15(14-10-7-8-11-16(14)23)19(25)22-17(18(21)24)20(2,3)4/h7-8,10-11,13,17H,5-6,9,12H2,1-4H3,(H2,21,24)(H,22,25)<br />
| StdInChIKey = IXUYMXAKKYWKRG-UHFFFAOYSA-N<br />
}}<br />
'''{{PAGENAME}}'''，化学名'''N-(1-氨甲酰基-2,2-二甲基丙基)-1-戊基吲哚-3-甲酰胺'''（{{langx|en|N-(1-amino-3,3-dimethyl-1-oxo-2-butanyl)-1-pentyl-1H-indole-3-carboxamide}}，也称为''' ADB-PICA'''）是一种含氮[[有机化合物]]，化学式[[C20H29N3O2|{{chem2|C20H29N3O2}}]]，属于3-[[吲哚]]甲酰胺衍生物，可作为[[合成大麻素]]，2013年在日本发现<ref>{{Cite journal | vauthors = Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y | title = Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products | doi = 10.1007/s11419-013-0182-9 | journal = Forensic Toxicology | year = 2013 | volume=31 | issue = 2 | pages=223–240| s2cid = 1279637 }}</ref>，2015年列入《[[非药用类麻醉药品和精神药品名录]]》<ref>{{cite wikisource|wslink=关于印发《非药用类麻醉药品和精神药品列管办法》的通知|wslanguage=zh|title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知|publisher=公安部 国家卫生计生委 食品药品监管总局 国家禁毒办|year=2015|month=9|day=24}}</ref>。<br />
<br />
==参考文献==<br />
{{reflist}}<br />
<br />
[[Category:大麻素]]<br />
[[Category:策划药]]<br />
[[Category:吲哚甲酰胺]]<br />
[[Category:叔丁基化合物]]</div>
imported>Jimmy-bot